335 related articles for article (PubMed ID: 11862188)
1. Cutaneous natural killer/T-cell lymphoma.
Radonich MA; Lazova R; Bolognia J
J Am Acad Dermatol; 2002 Mar; 46(3):451-6. PubMed ID: 11862188
[TBL] [Abstract][Full Text] [Related]
2. Blastic natural killer cell and extranodal natural killer cell-like T-cell lymphoma presenting in the skin: report of six cases from the UK.
Child FJ; Mitchell TJ; Whittaker SJ; Calonje E; Spittle M; Crocker J; Russell-Jones R
Br J Dermatol; 2003 Mar; 148(3):507-15. PubMed ID: 12653743
[TBL] [Abstract][Full Text] [Related]
3. Subcutaneous, blastic natural killer (NK), NK/T-cell, and other cytotoxic lymphomas of the skin: a morphologic, immunophenotypic, and molecular study of 50 patients.
Massone C; Chott A; Metze D; Kerl K; Citarella L; Vale E; Kerl H; Cerroni L
Am J Surg Pathol; 2004 Jun; 28(6):719-35. PubMed ID: 15166664
[TBL] [Abstract][Full Text] [Related]
4. Nasal and nasal-type T/NK-cell lymphoma with cutaneous involvement.
Kato N; Yasukawa K; Onozuka T; Kikuta H
J Am Acad Dermatol; 1999 May; 40(5 Pt 2):850-6. PubMed ID: 10321634
[TBL] [Abstract][Full Text] [Related]
5. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases.
Coupland SE; Foss HD; Assaf C; Auw-Haedrich C; Anastassiou G; Anagnostopoulos I; Hummel M; Karesh JW; Lee WR; Stein H
Ophthalmology; 1999 Nov; 106(11):2109-20. PubMed ID: 10571346
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous presentation of steroid responsive blastoid natural killer cell lymphoma.
Bower CP; Standen GR; Pawade J; Knechtli CJ; Kennedy CT
Br J Dermatol; 2000 May; 142(5):1017-20. PubMed ID: 10809865
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous extranasal NK/T-cell lymphoma.
Ruiz Villaverde R; Blasco Melguizo J; Juez Martel I; Linares Solano J; Naranjo Sintes R
J Eur Acad Dermatol Venereol; 2003 Jul; 17(4):434-6. PubMed ID: 12834454
[TBL] [Abstract][Full Text] [Related]
8. Blastic CD56+ natural killer-cell lymphoma with primary cutaneous manifestation.
Berger TG; Voll RE; Simon M; Kiesewetter F
Acta Derm Venereol; 2004; 84(1):53-6. PubMed ID: 15040479
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous CD56 positive natural killer and cytotoxic T-cell lymphomas.
Chattopadhyay A; Slater DN; Hancock BW
Int J Oncol; 2005 Jun; 26(6):1559-62. PubMed ID: 15870869
[TBL] [Abstract][Full Text] [Related]
10. CD2-, CD4+, CD56+ agranular natural killer cell lymphoma of the skin.
Uchiyama N; Ito K; Kawai K; Sakamoto F; Takaki M; Ito M
Am J Dermatopathol; 1998 Oct; 20(5):513-7. PubMed ID: 9790118
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic analysis of cutaneous lymphoma in taiwan: a high frequency of extranodal natural killer/t-cell lymphoma, nasal type, with an extremely poor prognosis.
Liao JB; Chuang SS; Chen HC; Tseng HH; Wang JS; Hsieh PP
Arch Pathol Lab Med; 2010 Jul; 134(7):996-1002. PubMed ID: 20586627
[TBL] [Abstract][Full Text] [Related]
12. CD56+ hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature.
Bekkenk MW; Jansen PM; Meijer CJ; Willemze R
Ann Oncol; 2004 Jul; 15(7):1097-108. PubMed ID: 15205205
[TBL] [Abstract][Full Text] [Related]
13. A case of natural killer/T cell lymphoma of the subcutis resembling subcutaneous panniculitis-like T cell lymphoma.
Yamashita Y; Tsuzuki T; Nakayama A; Fujino M; Mori N
Pathol Int; 1999 Mar; 49(3):241-6. PubMed ID: 10338081
[TBL] [Abstract][Full Text] [Related]
14. A case of CD30+ nasal natural killer/T-cell lymphoma.
Ferenczi K; Summers P; Aubert P; Cooper B; Meyerson H; Cooper KD; Honda K
Am J Dermatopathol; 2008 Dec; 30(6):567-71. PubMed ID: 19033930
[TBL] [Abstract][Full Text] [Related]
15. Classification of cytotoxic T-cell and natural killer cell lymphomas.
Jaffe ES; Krenacs L; Raffeld M
Semin Hematol; 2003 Jul; 40(3):175-84. PubMed ID: 12876666
[TBL] [Abstract][Full Text] [Related]
16. Nasal and nasal-type natural killer/T-cell lymphoma.
Hirakawa S; Kuyama M; Takahashi S; Yamasaki O; Kanzaki H; Teshima T; Harada M; Ma Y; Kawabata T; Yoshino T; Arata J
J Am Acad Dermatol; 1999 Feb; 40(2 Pt 1):268-72. PubMed ID: 10025761
[TBL] [Abstract][Full Text] [Related]
17. Relative frequency of the different types of cutaneous T cell and natural killer cell lymphomas in Korea based on the proposed WHO classification and the EORTC classification.
Chang SE; Jee MS; Kim KJ; Choi JH; Sung KJ; Moon KC; Koh JK
J Dermatol; 2003 Jan; 30(1):42-7. PubMed ID: 12598708
[TBL] [Abstract][Full Text] [Related]
18. Primary cutaneous extranodal natural killer/T cell lymphoma with delayed expression of CD56.
Kobayashi A; Goto H; Negishi-Asano A; Sowa-Osako J; Tanaka S; Ohe C; Kohashi K; Tsuruta D; Tateishi C
Eur J Dermatol; 2023 Dec; 33(6):705-706. PubMed ID: 38465562
[No Abstract] [Full Text] [Related]
19. Cytotoxic/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force Workshop.
Santucci M; Pimpinelli N; Massi D; Kadin ME; Meijer CJ; Müller-Hermelink HK; Paulli M; Wechsler J; Willemze R; Audring H; Bernengo MG; Cerroni L; Chimenti S; Chott A; Díaz-Pérez JL; Dippel E; Duncan LM; Feller AC; Geerts ML; Hallermann C; Kempf W; Russell-Jones R; Sander C; Berti E;
Cancer; 2003 Feb; 97(3):610-27. PubMed ID: 12548603
[TBL] [Abstract][Full Text] [Related]
20. Expression of killer cell inhibitory receptors is restricted to true NK cell lymphomas and a subset of intestinal enteropathy-type T cell lymphomas with a cytotoxic phenotype.
Dukers DF; Vermeer MH; Jaspars LH; Sander CA; Flaig MJ; Vos W; Willemze R; Meijer CJ
J Clin Pathol; 2001 Mar; 54(3):224-8. PubMed ID: 11253136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
